Live Breaking News & Updates on ஹெபடைடிஸ் மருந்து

Stay updated with breaking news from ஹெபடைடிஸ் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zydus Cadila DCGI nod hepatitis drug COVID19 treatment use


URL copied
Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment
Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India (DCGI) for the additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which the company sells under the brand name PegiHep has shown promising results in treating COVID-19, Zydus Cadila said in a statement.
The interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complications seen in the advanced stages of the disease, it added. ....

United States , Zydus Cadila , Sharvil Patel , Zydus Group , Drug Administration , Image Source , Drugs Controller General , Pegylated Interferon , Pegylated Interferon Alpha , Indian Innovation , United States Food , Cadila Healthcare , Dgci Nod , Hepatitis Drug , Covid 19 Treatment , Covid 19 , Corona Virus , Coronavirus Treatment , Drugs Controller General Of India , Alpha 2b , ஒன்றுபட்டது மாநிலங்களில் , ஜய்துச் காடிலா , ஷார்வில் படேல் , ஜய்துச் குழு , படம் மூல , மருந்துகள் கட்டுப்படுத்தி ஜநரல் ,